Supplementary Figure 1. The expression of miat/miR-22-3p/sirt1 in HCC senescence models and knockdown of miat suppresses HCC cell hepato-carcinogenesis. (A, B) The mRNA levels of miat in different concentration of H 2 O 2 or DOX induced HepG2 cellular senescence models. (C, D) The mRNA levels of miat in different concentration of H 2 O 2 or DOX induced SMMC-7721 cellular senescence models. (E, F) The mRNA levels of miR-22-3p in different concentration of H 2 O 2 or DOX induced HepG2 cellular senescence models. (G, H) The mRNA levels of miR-22-3p in different concentration of H 2 O 2 or DOX induced SMMC-7721 cellular senescence models. (I, J) The mRNA and protein levels of sirt1 in different concentration of H 2 O 2 or DOX induced HepG2 cellular senescence models. (K, L) The mRNA and protein levels of sirt1 in different concentration of H 2 O 2 or DOX induced SMMC-7721 cellular senescence models. The bars represent the mean and SD of three independent experiments; *P < 0.
. The bars represent the mean and SD of three independent experiments; *P < 0.05, **P < 0.01 and ***P < 0.001. (B, J, R) Cell senescence assay by SA-β-gal staining in human fibroblast 2BS, . (C, K, S) Cell cycle assay was performed in human fibroblast 2BS, . (D, L, T) Cell proliferations were measured using CCK-8 assays in normal human fibroblast 2BS, , n=4, *P < 0.05, **P < 0.01 and ***P < 0.001. (E, M, U) The mRNA levels of miR-22-3p in normal human fibroblast 2BS, . The bars represent the mean and SD of three independent experiments; *P < 0.05, **P < 0.01 and ***P < 0.001. (F, N, V) Cell senescence assay by SA-β-gal staining in normal human fibroblast 2BS, . (G, O, W) Cell cycle assay was performed in normal human fibroblast 2BS, . (H, P, X) Cell proliferations were measured using CCK-8 assays in normal human fibroblast 2BS, IMR-90 and MRC-5 infected with NC or miR-22-3p inhibitor (sh-miR-22), n=4, *P < 0.05, **P < 0.01 and ***P < 0.001. -22-3p(miR-22) / miR-22-3p inhibitor(sh-miR-22) . The bars represent the mean and SD of three independent experiments; *P < 0.05, **P < 0.01 and ***P < 0.001. (B, D) Cell proliferations were measured using CCK-8 assays in HepG2 infected with NC or miR- 22-3p(miR-22) / miR-22-3p inhibitor(sh-miR-22) , n=4, *P < 0.05, **P < 0.01 and ***P < 0.001. (E, F) cell colony formation assay was shown at 14 days after HepG2 infected with NC or miR- 22-3p(miR-22) / miR-22-3p inhibitor(sh-miR-22) , and the colony number per field were calculated. The bars represent the mean and SD of three independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001. (G, H) Representative images of HepG2 cell transwell migration assay, and the migratory cells were captured 24 hours after the cells were inoculated, respectively, and the results are summarized in the right panel. The bars represent the mean and SD of three independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001. (I, K) Representative images of wound-healing assay were captured at 0, 24, 48 and 72h hours after HepG2 infected with NC or miR- 22-3p(miR-22) The protein levels of sirt1, p53/p21 and p16/pRb were measured by western blotting. (H) RT-PCR analysis for the expression levels of the p53/p21 and p16/pRb signaling pathway in SMMC-7721 cells infected with PLKO.1, sh-miat, or coinfected with sh-miat with the miR-22-3p (miR-22 OE) / miR-22-3p inhibitor (miR-22 KD). The bars represent the mean and SD of three independent experiments; *P < 0.05, **P < 0.01 and ***P < 0.001. (I) Protein levels of sirt1, p53/p21 and p16/pRb were measured by western blotting in SMMC-7721 cells infected with PLKO.1, sh-miat, or coinfected with sh-miat with the miR-22-3p (miR-22 OE) / miR-22-3p inhibitor (miR-22 KD). (J) Protein levels of sirt1, p53/p21 and p16/pRb were measured by western blotting in SMMC-7721 cells with different treatments. (K-N) RT-PCR analysis for the expression levels of the p53/p21 and p16/pRb signaling pathway in SMMC-7721 cells with different treatments. The bars represent the mean and SD of three independent experiments; *P < 0.05, **P < 0.01 and ***P < 0.001. (O) RT-PCR analysis for the expression of selected SASP components (tnf-α, il-1α, il-1β, il-6 and il-8) was analyzed by quantitative PCR in sh-miat SMMC-7721 cells. The bars represent the mean and SD of three independent experiments; *P < 0.05, **P < 0.01 and ***P < 0.001. (P) RT-PCR analysis for the expression of selected SASP components (tnf-α, il-1α, il-1β, il-6 and il-8) was analyzed by quantitative PCR in SMMC-7721 cells infected with PLKO.1, sh-miat, or coinfected with sh-miat with the miR-22-3p (miR-22 OE) / miR-22-3p inhibitor (miR-22 KD). The bars represent the mean and SD of three independent experiments; *P < 0.05, **P < 0.01 and ***P < 0.001. (Q) RT-PCR analysis for the expression of selected SASP components. il-6 was analyzed by quantitative PCR in SMMC-7721 cells with different treatments. The bars represent the mean and SD of three independent experiments; *P < 0.05, **P < 0.01 and ***P < 0.001. (R) Cell proliferation was measured using CCK-8 assays in SMMC-7721 cells with different treatments; n=4, *P < 0.05, **P < 0.01 and ***P < 0.001. (S) The specific color corresponding to different experimental groups in Figure 8C -8E, 8K-8N, 8Q and 8R.
